Mark Jay Shlomchik BA, MD, PhD

Mark J. Shlomchik, M.D., Ph.D., succeeds founding department chair Olivera Finn, Ph.D., who will continue her research into peptide vaccines against pancreatic and colon cancers at Pitt. He is expected to start July 1. “Dr. Shlomchik has been very widely recognized for his research achievements,” said Arthur S. Levine, M.D., Pitt’s senior vice chancellor for the health sciences and dean, School of Medicine. “His research interests spanning basic to translational immunology mesh well with the institutional strengths of our immunology department and put him in a good position to further build them.

He added that while Dr. Shlomchik’s primary responsibility will be the leadership of his department, he will work closely with other important entities in the medical school which focus on various aspects of immunology, including the Thomas E. Starzl Transplantation Institute, the Center for Vaccine Research, and the University of Pittsburgh Cancer Institute.